Logo image of CMBTO.OL

CMB TECH NV (CMBTO.OL) Stock Fundamental Analysis

Europe - OSL:CMBTO - BE0003816338 - Common Stock

92.2 NOK
+0.1 (+0.11%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

4

Overall CMBTO gets a fundamental rating of 4 out of 10. We evaluated CMBTO against 62 industry peers in the Oil, Gas & Consumable Fuels industry. CMBTO scores excellent on profitability, but there are concerns on its financial health. CMBTO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMBTO was profitable.
CMBTO had a positive operating cash flow in the past year.
CMBTO had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBTO 4 years had a positive operating cash flow.
CMBTO.OL Yearly Net Income VS EBIT VS OCF VS FCFCMBTO.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

With a Return On Assets value of 4.58%, CMBTO perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
CMBTO has a better Return On Equity (29.01%) than 93.55% of its industry peers.
The Return On Invested Capital of CMBTO (3.97%) is worse than 66.13% of its industry peers.
CMBTO had an Average Return On Invested Capital over the past 3 years of 9.19%. This is in line with the industry average of 9.92%.
The last Return On Invested Capital (3.97%) for CMBTO is well below the 3 year average (9.19%), which needs to be investigated, but indicates that CMBTO had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROIC 3.97%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.19%
ROIC(5y)N/A
CMBTO.OL Yearly ROA, ROE, ROICCMBTO.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBTO has a better Profit Margin (25.21%) than 87.10% of its industry peers.
CMBTO's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.71%, CMBTO is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
CMBTO's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 54.54%, CMBTO is doing good in the industry, outperforming 62.90% of the companies in the same industry.
CMBTO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBTO.OL Yearly Profit, Operating, Gross MarginsCMBTO.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBTO is creating some value.
The number of shares outstanding for CMBTO has been reduced compared to 1 year ago.
Compared to 5 years ago, CMBTO has less shares outstanding
CMBTO has a worse debt/assets ratio than last year.
CMBTO.OL Yearly Shares OutstandingCMBTO.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBTO.OL Yearly Total Debt VS Total AssetsCMBTO.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that CMBTO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.72, CMBTO is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
CMBTO has a Debt/Equity ratio of 3.82. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.82, CMBTO is doing worse than 91.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.52
WACC7.69%
CMBTO.OL Yearly LT Debt VS Equity VS FCFCMBTO.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBTO has a Current Ratio of 0.82. This is a bad value and indicates that CMBTO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, CMBTO is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
CMBTO has a Quick Ratio of 0.82. This is a bad value and indicates that CMBTO is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBTO has a Quick ratio of 0.75. This is amonst the worse of the industry: CMBTO underperforms 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.75
CMBTO.OL Yearly Current Assets VS Current LiabilitesCMBTO.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The earnings per share for CMBTO have decreased strongly by -99.67% in the last year.
Measured over the past years, CMBTO shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
Looking at the last year, CMBTO shows a decrease in Revenue. The Revenue has decreased by -1.96% in the last year.
Measured over the past years, CMBTO shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-21.24%

3.2 Future

Based on estimates for the next years, CMBTO will show a very negative growth in Earnings Per Share. The EPS will decrease by -23.15% on average per year.
CMBTO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.70% yearly.
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBTO.OL Yearly Revenue VS EstimatesCMBTO.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBTO.OL Yearly EPS VS EstimatesCMBTO.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

CMBTO is valuated quite expensively with a Price/Earnings ratio of 461.00.
Compared to the rest of the industry, the Price/Earnings ratio of CMBTO indicates a slightly more expensive valuation: CMBTO is more expensive than 74.19% of the companies listed in the same industry.
CMBTO is valuated expensively when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 5.37, which indicates a rather cheap valuation of CMBTO.
Based on the Price/Forward Earnings ratio, CMBTO is valued cheaper than 95.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. CMBTO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 461
Fwd PE 5.37
CMBTO.OL Price Earnings VS Forward Price EarningsCMBTO.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

CMBTO's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CMBTO is more expensive than 70.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.12
CMBTO.OL Per share dataCMBTO.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The decent profitability rating of CMBTO may justify a higher PE ratio.
A cheap valuation may be justified as CMBTO's earnings are expected to decrease with -23.15% in the coming years.
PEG (NY)N/A
PEG (5Y)10.62
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%

0

5. Dividend

5.1 Amount

CMBTO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

OSL:CMBTO (10/3/2025, 7:00:00 PM)

92.2

+0.1 (+0.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners3.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.13B
Analysts83.64
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend56.55
Dividend Growth(5Y)116.35%
DP59.41%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.53%
Min EPS beat(2)-198.04%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-100.08%
Min EPS beat(4)-198.04%
Max EPS beat(4)-3.67%
EPS beat(8)4
Avg EPS beat(8)61.43%
EPS beat(12)7
Avg EPS beat(12)47.26%
EPS beat(16)10
Avg EPS beat(16)41.59%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)166.6%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-64.19%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)12.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)10.27%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 461
Fwd PE 5.37
P/S 1.92
P/FCF N/A
P/OCF 10.86
P/B 2.21
P/tB 2.57
EV/EBITDA 13.12
EPS(TTM)0.2
EY0.22%
EPS(NY)17.17
Fwd EY18.62%
FCF(TTM)-30.01
FCFYN/A
OCF(TTM)8.49
OCFY9.21%
SpS48.1
BVpS41.79
TBVpS35.84
PEG (NY)N/A
PEG (5Y)10.62
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROCE 5.15%
ROIC 3.97%
ROICexc 4.05%
ROICexgc 4.16%
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.19%
ROIC(5y)N/A
ROICexc(3y)10.15%
ROICexc(5y)N/A
ROICexgc(3y)10.2%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 492%
Cap/Sales 80.04%
Interest Coverage 1.85
Cash Conversion 42.05%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.75
Altman-Z 0.72
F-Score2
WACC7.69%
ROIC/WACC0.52
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-21.24%
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A
EBIT growth 1Y-41.59%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year116.95%
EBIT Next 3Y52.74%
EBIT Next 5YN/A
FCF growth 1Y-427.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.74%
OCF growth 3YN/A
OCF growth 5Y11.04%